Cardio-renal protective effect and safety of sodium-glucose cotransporter 2 inhibitors for chronic kidney disease patients with eGFR < 60 mL/min/1.73 m2: a systematic review and meta-analysisYaru Zhang, Nanlan Chen, Junhui Luo et al.|BMC Nephrology|2024Cited by 11